HIGHLIGHTS
- who: Stefanie Quach from the Neuropathological analysis All tumors were classified according to WHO , [30] at the Center for Neuropathology and Prion Research of the University of Munich and re-classified according to WHO , [2] retrospectively for the purpose of this studyIDH mutation status was determined by pyrosequencing. Sanger sequencing was used to detect telomerase reverse transcriptase (TERT) promoter mutations, as well as microsatellite analysis for detection of, p and, q deletions. u00adO6-methylguanine-DNA methyltransferase (MGMT) promoter methylation was analyzed by methylation-specific PCR and sequencing analysis. MGMT promoter methylation have published the research work: TSPO . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.